FAQ/Help |
Calendar |
Search |
Today's Posts |
|
ALS News & Research For postings of news or research links and articles related to ALS |
|
Thread Tools | Display Modes |
11-02-2016, 08:58 AM | #1 | |||
|
||||
Grand Magnate
|
MediciNova Announces MN-166 (ibudilast) ALS Abstract Accepted for Presentation at the 27th International Symposium on ALS/MND in Dublin, Ireland
https://globenewswire.com/news-release/2016/10/30/884427/0/en/MediciNova-Announces-MN-166-ibudilast-ALS-Abstract-Accepted-for-Presentation-at-the-27th-International-Symposium-on-ALS-MND-in-Dublin-Ireland.html |
|||
Reply With Quote |
|
|
Similar Threads | ||||
Thread | Forum | |||
MediciNova Announces FDA Granted Orphan Drug Designation to MN-166 (ibudilast) for Am | ALS News & Research | |||
NeuroDerm Announces Presentation of ND0612 Phase 1 and Phase 2 Results at the 2013 In | Parkinson's Disease | |||
Oxford BioMedica Announces Presentation of New Clinical Data From ProSavin(R) Phase I | Parkinson's Disease |